HARPOON THERAPEUTICS INC (HARP)

US41358P2056 - Common Stock

23.01  +0.02 (+0.09%)

After market: 23 -0.01 (-0.04%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
37.34M31.92M23.65M17.44M5.78M
Operating Expenses
74.74M100.24M90.46M68.78M63.98M
Research and Development
58.64M81.39M72.12M52.57M41.59M
Selling, General, and Administrative Expenses
16.10M18.85M18.33M16.21M22.39M
Operating Income
-37.40M-68.33M-66.80M-51.33M-58.21M
Interest Income/Expense
-1.89M780.00K240.00K1.45M2.68M
Other Income/Expense
8.77M-180.00K-210.00K-30.00K-40.00K
Non Recurring Items
N/A0.00-49.95MN/AN/A
Income Before Taxes
-30.50M-67.73M-116.72M-49.91M-55.57M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-30.50M-67.73M-116.72M-49.91M-55.57M
EBITDA
-35.45M-65.97M-64.61M-49.25M-57.31M
 
Per Share Data
EPS Diluted Total Ops
-8.72-20.42-36.13-19.96-25.60
Non GAAP EPS
-8.76-20.50-2.06-2.00-2.64
 
Statistics
Profit Margin
-81.68%-212.19%-493.53%-286.18%-961.42%
Operating Profit Margin
-100.16%-214.07%-282.45%-294.32%-1007.09%

All data in USD

Charts